Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Par Formulations Pvt. Ltd.

Division of Endo International PLC
www.edictpharmaceuticals.com

Latest From Par Formulations Pvt. Ltd.

Start-Up Quarterly Statistics: A Record-Breaking Q2 As Financings Surge

Biopharma start-ups had a record-breading quarter in terms of fundraising. A review of biopharma start-up deal-making and financing activity from April through June 2018, based on data from Strategic Transactions.

Financing StartUps and SMEs

Deal Watch: Gilead’s Immunology Collaboration With Verily Continues Pivot Away From Virology

Gilead’s tie-up with Google’s Verily will explore the immunological underpinnings of rheumatoid arthritis, lupus and GI disorders. Janssen acquires BeneVir and its oncolytic virus expertise, while United Therapeutics buys out SteadyMed.
Deals Commercial

Generic Firms Fear FDA Pill Size Guidance Helps Brands Stifle Competition

FDA final guidance excludes attachment on capsules but otherwise is virtually identical to draft; GPhA had argued for flexibility in product design to avoid brand patents.

BioPharmaceutical Consumer

Generic Firms Fear FDA Pill Size Guidance Helps Brands Stifle Competition

FDA final guidance excludes attachment on capsules but otherwise is virtually identical to draft; GPhA had argued for flexibility in product design to avoid brand patents.

BioPharmaceutical Consumer
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Edict Pharmaceuticals Pvt. Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Endo International PLC
  • Senior Management
  • Muthusamy Shanmugam, CEO
    Jaganathan Jayaseelan, Pres.
  • Contact Info
  • Par Formulations Pvt. Ltd.
    Phone: 44 27474516
    New No. 1/58 Pudupakkam Main Rd.
    Kelambakkam
    Tamil Nadu, 603103
    India
Advertisement
Advertisement
UsernamePublicRestriction

Register